Deoxycholic Acid

Every day your liver sends bile into your gut to help digest fat, and most of it gets recycled. The part that reaches your colon is reworked by bacteria, and DCA (deoxycholic acid) is the main thing they make from it. How much ends up in your stool says something about which bacteria you carry, how you eat, and how your bowel and liver are doing.

Research ties low stool DCA to ulcerative colitis, scarring liver disease, and a less diverse gut, while high levels track with colorectal cancer risk. This is a research-grade marker without standard clinical cutpoints, so a single number won't diagnose anything. What it gives you is a baseline on a part of your gut biology that routine blood work doesn't measure at all.

Where Stool DCA Comes From

Your liver builds bile acids out of cholesterol. The ones it makes directly are called primary bile acids. When they reach the colon, a small group of bacteria chemically trims them into secondary bile acids, and DCA is the most abundant of these.

The bacteria that make DCA belong mostly to a group researchers label Clostridium subcluster XIVa, along with the Lachnospiraceae and Ruminococcaceae families. In one study, having fewer of these bacteria tracked closely with weaker bile acid conversion, and the authors proposed stool bile acid profiles as a practical way to estimate how active those bacteria are.

So your result reflects two things at once: how much bile reaches your colon, and how well your bacteria convert it. Keep both in mind, because they explain why the number can be low for one reason in one person and high for a different reason in another.

Colorectal Cancer Risk

Higher stool DCA is the finding most often linked to colon cancer. An updated review pooling earlier studies found higher stool levels of DCA, along with cholic, chenodeoxycholic, and ursodeoxycholic acids, in people at higher risk and in people with colorectal cancer. The authors described this as a possible association with risk, and that is as far as the evidence currently goes.

High stool DCA also tends to show up alongside high-fat, low-fiber Western eating patterns. A small study comparing Alaska Native people, who have high colorectal cancer rates, with rural Africans at low risk linked the high-fat, low-fiber diet to a colon environment that favors tumor growth.

What this means for you: a high result doesn't mean you have cancer, and this test doesn't replace colon cancer screening. If your level is high and colon cancer runs in your family, treat it as one more reason to keep your screening current, since screening is where the proven protection comes from.

Ulcerative Colitis and Crohn's Disease

Ulcerative colitis runs the other way. In one study, people with active ulcerative colitis had less DCA and related secondary bile acids in their stool than healthy people or people with Crohn's disease. The lower their secondary bile acids, the higher their stool inflammation marker (calprotectin) and blood inflammation marker (C-reactive protein) tended to be. People with ulcerative colitis whose stools were watery also had less DCA than those with normal stools, a link that didn't appear in Crohn's disease.

Other work points the same way. The bacteria that produce DCA are depleted in inflammatory bowel disease. In a study that combined patient samples with mouse experiments, losing secondary bile acids through disturbed gut bacteria promoted gut inflammation in the mice, and the authors proposed restoring them as a possible treatment. That causal step has been shown in animals, not yet in people. The mouse evidence isn't uniform either: another mouse study found that added DCA made chemically induced colitis worse.

Bile acid profiles have also been tried as a way to tell ulcerative colitis apart from Crohn's disease. The best performers were glycine-linked forms of secondary bile acids, and they were right only part of the time, so the authors suggested using these profiles alongside other markers.

What this means for you: low DCA together with loose stools or a high calprotectin is worth a gastroenterology workup. Low DCA with normal bowel habits and normal inflammation markers is far less concerning on its own.

Diarrhea, Constipation, and Irritable Bowel Syndrome

Bile acids help set how fast and how loosely your bowel moves, so stool DCA shows up in studies of everyday bowel complaints as well as disease.

Sources: Wei et al.; Vijayvargiya et al.; Shin et al.

What this means for you: if you live with chronic loose stools or constipation, your DCA result is a clue about how bile is being handled in your colon. It is most useful read next to your symptoms and other stool markers, because how fast your colon moves can matter as much as the bile acids themselves.

Liver Disease

In cirrhosis, the conversion of primary to secondary bile acids drops, especially in advanced disease, and the drop follows the loss of key gut bacteria. Infants with cholestatic jaundice, where bile doesn't drain properly, show the same pattern of disturbed bacteria and altered bile acid handling.

Primary sclerosing cholangitis is a disease that scars the bile ducts. In a study of 26 people with it, stool DCA was lower than in healthy people, and those with more DCA had lower bilirubin in their blood. Bilirubin rises when bile can't drain properly, so in that study more DCA lined up with healthier bile flow.

Fatty liver goes the other direction. In adults with fatty liver disease, stool bile acids were higher than in healthy people, and in a study of people with biopsy-confirmed fatty liver disease, stool and blood bile acid levels rose with each stage of liver scarring. Children with fatty liver tied to metabolic problems also carried specific bacteria linked to higher DCA and to markers of worsening disease.

These results only look contradictory. Fatty liver came with more total bile acids in stool, while cirrhosis and bile duct disease come with poorer bile flow and fewer converting bacteria, so the same molecule ends up high in one disease and low in another. Your number means little until you know which way your liver and gut are being pushed, which is why liver blood tests belong next to it.

Heart and Kidney Findings From Other Measurements

The studies linking DCA to hard outcomes like death measured it in blood, which is a different measurement from stool. In about 3,100 people with chronic kidney disease, higher blood DCA went with higher risk of kidney failure and death, independent of other risk factors. In a smaller kidney disease study, higher blood DCA also went with more calcium in the heart arteries and thinner bones.

In about 1,700 people with heart disease, higher blood levels of several bile acids, DCA among them, went with a lower risk of dying. Those blood findings point in opposite directions and tell you nothing direct about your stool number.

The long-term stool studies measured total bile acid output rather than DCA. In two small studies followed for years, lower total bile acid excretion predicted stroke, heart disease, and death, which the authors read as a sign that the body was clearing cholesterol poorly.

Why a Single Reading Can Fool You

The biggest problem with one stool sample is how much it drifts. These are the factors most likely to throw off a reading:

• Month-to-month drift: in a population study, stool bile acids could be measured consistently in the lab, but a person's level six months later often didn't match their first one well.
• Stool consistency: watery stools in ulcerative colitis went with lower DCA, so a sample collected during a bout of diarrhea may read lower than your usual level.
• Bile acid binding drugs: in a trial of people with bile acid diarrhea, colesevelam pushed more bile acids out in stool. That reflects the drug grabbing bile, so a result taken while you're on it says little about your gut bacteria.
• Drugs that reshape gut bacteria: acid-blocking pills (proton pump inhibitors), metformin, antibiotics, and laxatives are strongly tied to changes in gut bacteria in large analyses. Their effect on stool DCA specifically hasn't been confirmed, so note them when you test.

Labs also measure stool bile acids with different techniques, and occasional lab factors can affect a result, so compare numbers only from the same lab.

Tracking Your Trend

Because a single stool sample drifts so much over months, several readings tell you more than one. If you want to follow this marker, get a baseline, retest in 3 to 6 months if you change your diet or start a new medication, and after that a yearly check is enough to keep a running record. Use the same lab each time, collect during an ordinary stretch of eating and bowel habits, and write down any new medications from the prior weeks.

A steady fall across several samples, especially alongside new loose stools, means far more than one low result. The way you eat tracks with this number in observational human studies, so repeat testing may show whether a change in diet registered in your gut. There are no standard cutpoints yet, so your own earlier results are the most useful comparison you have.

What to Do With an Unexpected Result

An out-of-pattern result is a prompt to look at the rest of the picture. These combinations should change what you do next:

• Low DCA with gut symptoms: if you also have ongoing diarrhea or blood in your stool, add stool calprotectin and a stool blood test, and see a gastroenterologist promptly if either is abnormal or you're seeing blood.
• Low DCA with liver signals: if your liver enzymes or bilirubin are off, get a full liver panel and involve a liver specialist.
• High DCA with colon cancer in the family: make sure your colon cancer screening is on schedule, and lean toward the earlier, more frequent end.
• High DCA with fatty liver risk: if you carry extra weight or have high triglycerides or insulin resistance, check liver enzymes and consider liver imaging.

Screening is where the strongest outcome evidence sits. Completing stool-based screening with fecal immunochemical testing (FIT) was tied to a lower risk of dying from colorectal cancer across racial and ethnic groups, and attending an organized FIT program was linked to about a third fewer colorectal cancers. Those studies tested screening rather than DCA, but they show where a worrying result should push you.

If your DCA is out of pattern and everything else looks normal, retest in 3 to 6 months before acting on it. A result that stays unusual across two or three samples is worth bringing to a gastroenterologist along with your symptom history and other stool and liver results.